First Time Loading...

Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Updated: Apr 29, 2024

Intrinsic Value

MEB doesn't have a meaningful market cap.
MEB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. [ Read More ]

The intrinsic value of one MEB stock under the Base Case scenario is 0.001 AUD. Compared to the current market price of 0.02 AUD, Medibio Ltd is Overvalued by 96%.

Key Points:
MEB Intrinsic Value
Base Case
0.001 AUD
Overvaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medibio Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MEB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medibio Ltd

Provide an overview of the primary business activities
of Medibio Ltd.

What unique competitive advantages
does Medibio Ltd hold over its rivals?

What risks and challenges
does Medibio Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medibio Ltd.

Provide P/S
for Medibio Ltd.

Provide P/E
for Medibio Ltd.

Provide P/OCF
for Medibio Ltd.

Provide P/FCFE
for Medibio Ltd.

Provide P/B
for Medibio Ltd.

Provide EV/S
for Medibio Ltd.

Provide EV/GP
for Medibio Ltd.

Provide EV/EBITDA
for Medibio Ltd.

Provide EV/EBIT
for Medibio Ltd.

Provide EV/OCF
for Medibio Ltd.

Provide EV/FCFF
for Medibio Ltd.

Provide EV/IC
for Medibio Ltd.

What are the Revenue projections
for Medibio Ltd?

How accurate were the past Revenue estimates
for Medibio Ltd?

What are the Net Income projections
for Medibio Ltd?

How accurate were the past Net Income estimates
for Medibio Ltd?

What are the EPS projections
for Medibio Ltd?

How accurate were the past EPS estimates
for Medibio Ltd?

What are the EBIT projections
for Medibio Ltd?

How accurate were the past EBIT estimates
for Medibio Ltd?

Compare the revenue forecasts
for Medibio Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medibio Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medibio Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medibio Ltd compared to its peers.

Compare the P/E ratios
of Medibio Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Medibio Ltd with its peers.

Analyze the financial leverage
of Medibio Ltd compared to its main competitors.

Show all profitability ratios
for Medibio Ltd.

Provide ROE
for Medibio Ltd.

Provide ROA
for Medibio Ltd.

Provide ROIC
for Medibio Ltd.

Provide ROCE
for Medibio Ltd.

Provide Gross Margin
for Medibio Ltd.

Provide Operating Margin
for Medibio Ltd.

Provide Net Margin
for Medibio Ltd.

Provide FCF Margin
for Medibio Ltd.

Show all solvency ratios
for Medibio Ltd.

Provide D/E Ratio
for Medibio Ltd.

Provide D/A Ratio
for Medibio Ltd.

Provide Interest Coverage Ratio
for Medibio Ltd.

Provide Altman Z-Score Ratio
for Medibio Ltd.

Provide Quick Ratio
for Medibio Ltd.

Provide Current Ratio
for Medibio Ltd.

Provide Cash Ratio
for Medibio Ltd.

What is the historical Revenue growth
over the last 5 years for Medibio Ltd?

What is the historical Net Income growth
over the last 5 years for Medibio Ltd?

What is the current Free Cash Flow
of Medibio Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medibio Ltd.

Financials

Balance Sheet Decomposition
Medibio Ltd

Current Assets 304.5k
Cash & Short-Term Investments 214.1k
Other Current Assets 90.4k
Non-Current Assets 7.8m
PP&E 107.5k
Intangibles 7.6m
Other Non-Current Assets 15.2k
Current Liabilities 1.8m
Accounts Payable 1.4m
Accrued Liabilities 143.1k
Other Current Liabilities 234.9k
Efficiency

Earnings Waterfall
Medibio Ltd

Revenue
963.8k AUD
Cost of Revenue
-160 AUD
Gross Profit
963.6k AUD
Operating Expenses
-2.8m AUD
Operating Income
-1.8m AUD
Other Expenses
-1.3m AUD
Net Income
-3.1m AUD

Free Cash Flow Analysis
Medibio Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MEB Profitability Score
Profitability Due Diligence

Medibio Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROIC
20/100
Profitability
Score

Medibio Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

MEB Solvency Score
Solvency Due Diligence

Medibio Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
67/100
Solvency
Score

Medibio Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEB Price Targets Summary
Medibio Ltd

There are no price targets for MEB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MEB Price
Medibio Ltd

1M 1M
-
6M 6M
+0%
1Y 1Y
+0%
3Y 3Y
-88%
5Y 5Y
-94%
10Y 10Y
-100%
Annual Price Range
0.02
52w Low
0.02
52w High
0.04
Price Metrics
Average Annual Return -28.38%
Standard Deviation of Annual Returns 19.03%
Max Drawdown -95%
Shares Statistics
Market Capitalization 122m AUD
Shares Outstanding 6 100 743 763
Percentage of Shares Shorted
N/A

MEB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medibio Ltd Logo
Medibio Ltd

Country

Australia

Industry

Health Care

Market Cap

122m AUD

Dividend Yield

0%

Description

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

Contact

VICTORIA
South Melbourne
L 4 100 Albert Rd
http://medibio.com.au/

IPO

2001-01-29

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one MEB stock?

The intrinsic value of one MEB stock under the Base Case scenario is 0.001 AUD.

Is MEB stock undervalued or overvalued?

Compared to the current market price of 0.02 AUD, Medibio Ltd is Overvalued by 96%.